1. Home
  2. KITT vs PFSA Comparison

KITT vs PFSA Comparison

Compare KITT & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

HOLD

Current Price

$0.90

Market Cap

8.1M

Sector

Industrials

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.10

Market Cap

9.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KITT
PFSA
Founded
2014
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
9.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KITT
PFSA
Price
$0.90
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.1M
54.5M
Earning Date
11-14-2025
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,688,840.00
N/A
Revenue This Year
$2,936.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
95.38
122.22
52 Week Low
$0.69
$0.07
52 Week High
$54.36
$12.76

Technical Indicators

Market Signals
Indicator
KITT
PFSA
Relative Strength Index (RSI) 45.97 N/A
Support Level $0.69 N/A
Resistance Level $1.10 N/A
Average True Range (ATR) 0.10 0.00
MACD 0.04 0.00
Stochastic Oscillator 50.94 0.00

Price Performance

Historical Comparison
KITT
PFSA

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: